全部分类
  • N-Arachidonoyl Dopamine-d8
N-Arachidonoyl Dopamine-d8的可视化放大

N-Arachidonoyl Dopamine-d8

An internal standard for the quantification of N-arachidonoyl dopamine

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

N-Arachidonoyl Dopamine-d8的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 100ug
    ¥937.00
    750.00
    - +
  • 500ug
    ¥4162.00
    3330.00
    - +
  • 1mg
    ¥7387.00
    5910.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx23062
  • CAS: 1159908-42-5
  • 别名: NADAd8
  • 分子式: C28H33D8NO3
  • 分子量: 447.6
  • 纯度: >98%
  • 溶解度: 0.1 M Na2CO3: Colloidal suspension @ 100 μg/,DMF: Miscible,DMSO: Miscible,Ethanol: Miscible,Ethanol:PBS (pH 7.2)(1:1): 100 μg/ml (colloidal suspensio
  • 储存: Store at -20°C
  • 库存: 现货

Background

N-Arachidonoyl dopamine-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of N-arachidonoyl dopamine by GC- or LC-mass spectrometry. Several different arachidonoyl amino acids, including NADA, have been isolated and characterized from bovine brain.1 NADA is the amide of the neurotransmitter dopamine and arachidonic acid. NADA is a CB1-selective cannabinoid agonist, inducing the typical tetrad of hypothermia, analgesia, catalepsy, and hypomotility in rats which exceeds that of anandamide (AEA).2 NADA is a full agonist at the vanilloid receptor 1, but is inactive on the dopaminergic D1 and D2 receptors. NADA is also a potent inhibitor (IC50 = 0.25 µM) of the proliferation of MCF-7 breast carcinoma cells. Recent reports of NADA's endothelium-dependent vasodilation indicate that some of its cannabinergic activities antagonized by SR141716A may be non-CB1/CB2 dependent.3



1.Huang, S.M., Bisogno, T., Petros, T.J., et al.Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits painThe Journal of Biological Chemisty276(46)42639-42644(2001) 2.Bisogno, T., Melck, D., Bobrov, M.Y., et al.N-acyl-dopamines: Novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivoBiochem. J.351(Pt 3)817-824(2001) 3.Randall, M., and Maxey, K.M.Personal Communication(2003)

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算